M&A Deal Summary |
|
---|---|
Date | 2013-10-29 |
Target | Lap-Band System |
Sector | Healthcare Services |
Buyer(s) | Apollo Endosurgery |
Sellers(s) | Allergan |
Deal Type | Divestiture |
Deal Value | 110M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2005 |
Sector | Medical Products |
Apollo Endosurgery, Inc. (old) is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 500 million people globally, as well as other gastrointestinal disorders.
DEAL STATS | # |
---|---|
Overall | 1 of 2 |
Sector (Healthcare Services) | 1 of 1 |
Type (Divestiture) | 1 of 2 |
Country (United States) | 1 of 2 |
Year (2013) | 1 of 2 |
Size (of disclosed) | 2 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-12-02 |
Allergan - Obesity Intervention Division
Irvine, California, United States Allergan, Inc. - Obesity Intervention Division is a manufacturer and sells weight loss solutions comprised of the LAP-BAND® adjustable gastric banding system and the ORBERA™ intra-gastric balloon system. |
Buy | $110M |
Category | Company |
---|---|
Founded | 1948 |
Sector | Life Science |
Employees | 11,400 |
Allergan, Inc. is a pharmaceutical company. Allergan's products include ophthalmic pharmaceuticals, dermatology products, and neurological products.
DEAL STATS | # |
---|---|
Overall | 1 of 3 |
Sector (Healthcare Services) | 1 of 1 |
Type (Divestiture) | 1 of 3 |
Country (United States) | 1 of 3 |
Year (2013) | 1 of 2 |
Size (of disclosed) | 3 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-04-12 |
Exemplar Pharma
Fall River, Massachusetts, United States Exemplar Pharma LLC manufacture of nasal and inhalation products targeting lungs, nasal passages, and the buccal cavity. |
Buy | $20M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-12-02 |
Allergan - Obesity Intervention Division
Irvine, California, United States Allergan, Inc. - Obesity Intervention Division is a manufacturer and sells weight loss solutions comprised of the LAP-BAND® adjustable gastric banding system and the ORBERA™ intra-gastric balloon system. |
Sell | $110M |